DrugPatentWatch Database Preview
BOTOX Drug Profile
Summary for Tradename: BOTOX
| Patents: | 41 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Drug Prices: | Drug price information for BOTOX |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for BOTOX |
Pharmacology for BOTOX
| Mechanism of Action | Acetylcholine Release Inhibitors |
Company Disclosures: US Patents for BOTOX
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | The Regents of the University of Colorado (Boulder, CO) | 2017-07-15 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2013-12-28 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2013-12-28 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2013-12-28 | RX | company | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for BOTOX
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | NANOMED SKINCARE, INC. (Cupertino, CA) | 2039-02-26 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2039-02-26 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | 2034-03-16 | RX | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for BOTOX
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1563843 | Start Trial |
| Germany | 69835911 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2009040809 | Start Trial |
| Germany | 122009000038 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BOTOX
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| SPC/GB12/053 | United Kingdom | Start Trial | PRODUCT NAME: BOTULINUM TOXIN; REGISTERED: UK PL 00426/0074-0110 20120924; UK PL 00426/0118-0030 20120924; UK PL 00426/0119-0012 20120924; REASON FOR LAPSE: SURRENDERED |
| C300654 | Netherlands | Start Trial | PRODUCT NAME: BOTULINUM TOXINE, TYPE A; NAT. REGISTRATION NO/DATE: RVG 17379RVG 32957RVG 32958 20131029; FIRST REGISTRATION: |
| C02145629/01 | Switzerland | Start Trial | FORMER OWNER: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE, US |
| CA 2013 00041 | Denmark | Start Trial | |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
